4DX.AX 4DMedical Limited

P/E --
Forward P/E -221.02563
Price/Sales 367.16794
Beta 1.949
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 4DMedical is trading 11% up with no confirmed company-specific explanation

4DMedical is trading at A$2.39, up 11.16%, with no confirmed company-specific announcement identified to explain the rise. - The company’s recent ASX response...

πŸ”΄ 4DMedical is trading 10.79% down with no confirmed catalyst identified

4DMedical is trading at A$2.15, down 10.79%, with no confirmed catalyst identified for the November 4 decline. - 4DMedical previously told the ASX it knew of...

πŸ”΄ 4DMedical is trading 12.86% down

4DMedical is trading at A$2.10, down 12.86%, with no clear company announcement or confirmed catalyst identified for the November 4 decline. - In its November...

πŸ”΄ 4DMedical is trading 7.3% down today

4DMedical is trading at A$2.41, down 7.31%, with the reason for the November 3 decline unclear. - No new company-specific catalyst for November 3 was...

πŸ”΄ 4DMedical is trading 7.1% down

4DMedical is trading 7.12% lower at A$2.42, with no specific catalyst established for the decline. - Available price context indicates a significant decline...

🟒 4DMedical is trading 7% up today after saying increased short interest may explain trading

4DMedical is trading at A$2.60, up 6.56%, after saying it believes increased short interest was responsible for recent trading. - On November 2, it told the...

🟒 4DMedical is trading 10.45% up today as issuer cites increased short interest

4DMedical is trading up 10.45% at A$2.69 on November 2, 2026, with the company saying it believes increased short interest is responsible. - The company told...

🟒 4DMedical is trading 5.74% up with no confirmed catalyst

4DMedical is trading 5.74% up at A$2.58, with no verified announcement explaining the November 2 rise. - The latest reported ASX notice says trading was...

4DMedical's 25% Plunge Raises a Stark Question: Can the Lung-Imaging Pioneer Fund Its Way to Profitability Without Crushing Shareholders?

4DMedical's Record Scans Couldn't Stop a 26% Crash β€” Can A$242 Million in Cash Outrun a Widening Burn? Shares in 4DMedical (ASX:4DX) suffered their worst...

πŸ”΄ 4DMedical is trading 25.6% down after quarterly cash outflows raised funding concerns

4DMedical is trading 25.61% down at A$2.44 in the latest session, identified as October 30 rather than November 2 trading, after investors reassessed its...

πŸ”΄ 4DMedical is trading 10% down β€” catalyst remains unclear

4DMedical is trading at A$2.95, down 10.06%, with the reason for the October 30 decline unclear. - No verified company-specific announcement or clear catalyst...

πŸ”΄ 4DMedical is trading 6.1% down

4DMedical is trading at A$3.08, down 6.10%, with no verified catalyst identified for the October 30 decline. - The October 28 quarterly report showed revenue...

πŸ”΄ 4DMedical is trading 5.5% down

4DMedical is trading 5.5% down at A$3.24; available evidence does not establish a specific cause for the decline. - The company released its Q1 FY27 quarterly...

🟒 4DMedical is trading 5.54% up on October 28, 2026 β€” catalyst remains uncertain

4DMedical is trading up 5.54% at A$3.81, with no clear company-specific announcement explaining the move identified in available search results. - The latest...

πŸ”΄ 4DMedical is trading 5% down amid Australian IT weakness

4DMedical is trading 5.38% lower at A$3.87; Australian IT weakness may have contributed, but no direct cause is established. - No new company-specific...

πŸ”΄ 4DMedical is trading 5% down today amid broader risk-off sentiment

4DMedical is trading 5.13% lower at A$3.88, with no company-specific announcement identified to explain the decline. - October 16 filings covered an AGM...

🟒 4DMedical is trading 7.37% up

4DMedical is trading at A$4.08, having closed October 15 up 7.37% from the previous close of A$3.80, amid reports of a bounce from short-term technical...

🟒 4DMedical is trading 5.3% up with no confirmed catalyst

4DMedical is trading 5.3% higher at A$4.00, with no clear catalyst identified. - Available reporting says it fell 6.86% on October 14, without identifying a...

πŸ”΄ 4DMedical is trading 7% down with no company-specific catalyst identified

4DMedical is trading at A$3.80, down 6.86% from the prior close of A$4.08; no specific company announcement or catalyst explaining the October 14 decline was...

πŸ”΄ 4DMedical is trading 5.15% down β€” catalyst unconfirmed

4DMedical is trading at A$3.87, down 5.15%, with the decline’s specific reason unconfirmed. - No confirmed company announcement or specific catalyst...